.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The BEST randomized clinical trial compared laparoscopic sleeve gastrectomy with Roux-en-Y gastric bypass in adults undergoing metabolic surgery. The study found broadly comparable major short-term surgical safety, while highlighting differences in weight reduction and metabolic effects between the procedures. Rather than identifying a single universally superior operation, the trial reinforces the idea that procedure selection should be individualized. Gastric bypass may be particularly attractive when stronger metabolic effect or reflux control is a priority, while sleeve gastrectomy can offer technical simplicity and avoids creation of a gastrointestinal anastomosis. These differences matter because obesity surgery is not simply a weight-loss procedure; it changes gastrointestinal physiology and can influence diabetes, lipid management, reflux and medication needs. For surgeons, the practical message is to match procedure choice to baseline disease, comorbidities, anatomy, patient preferences and long-term follow-up capacity. High-quality randomized evidence such as BEST helps move counseling away from generic comparisons and toward personalized bariatric pathways.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The BEST randomized clinical trial compared laparoscopic sleeve gastrectomy with Roux-en-Y gastric bypass in adults undergoing metabolic surgery. The study found broadly comparable major short-term surgical safety, while highlighting differences in weight reduction and metabolic effects between the procedures. Rather than identifying a single universally superior operation, the trial reinforces the idea that procedure selection should be individualized. Gastric bypass may be particularly attractive when stronger metabolic effect or reflux control is a priority, while sleeve gastrectomy can offer technical simplicity and avoids creation of a gastrointestinal anastomosis. These differences matter because obesity surgery is not simply a weight-loss procedure; it changes gastrointestinal physiology and can influence diabetes, lipid management, reflux and medication needs. For surgeons, the practical message is to match procedure choice to baseline disease, comorbidities, anatomy, patient preferences and long-term follow-up capacity. High-quality randomized evidence such as BEST helps move counseling away from generic comparisons and toward personalized bariatric pathways.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
